How many employees does Cerus have this year?
Cerus has 254 undefined employees this year.
Cerus Employees 2024
Cerus Employees
254
Ticker
CERS
ISIN
US1570851014
WKN
905249
In 2024, Cerus employed 254 people, a 0% change from the 254 number of employees in the previous year.
Cerus Aktienanalyse
What does Cerus do?
Cerus Corporation is a biotechnology company specialized in the development and marketing of products for the processing and transfusion of blood products. The company was founded in 1991 and is headquartered in Concord, California. Cerus Corporation is listed on the NASDAQ stock exchange and employs approximately 450 employees worldwide. The history of Cerus Corporation began when its founder, Stephen Isaacs, received a blood transfusion and subsequently became infected with the Hepatitis B virus. This incident inspired him to start a company focusing on the development of technologies for the safe transfusion of blood products. In 1993, Cerus Corporation introduced its first product, the Intercept Blood System. This system utilized ultraviolet light and chemicals to deactivate pathogens such as viruses, bacteria, and parasites in blood. The business model of Cerus Corporation revolves around the development and distribution of products for medical needs. The company's focus is on the processing of blood products such as platelets, plasma, and red blood cells to reduce the risk of infectious diseases and other potentially harmful side effects in blood transfusions. Cerus also provides training and technical support for its products. Cerus Corporation has several divisions, including the Intercept Blood System, Blood Center Technology, and Innovative Technology. The Intercept Blood System division is the largest and most popular, offering products such as the Intercept Blood System for platelets and plasma, the Intercept Blood System for red blood cells, the Intercept Blood System for PAS (reduced volume blood bank) and the Intercept Blood System for Fresh Frozen Plasma. Cerus Corporation's Blood Center Technology division provides technologies and devices for blood banks and transfusion services, including transfusion safety systems and blood testing devices. The Innovative Technology division specializes in the development of new technologies and products. Another product of Cerus Corporation is INTERCEPT FDA Approved Plasma, which was approved by the US Food and Drug Administration (FDA) in 2018. The plasma is made from donated blood and processed using the INTERCEPT technology. The INTERCEPT technology decontaminates various blood components, increasing their safety in transfusions. Cerus Corporation has achieved significant success in the medical technology industry. Cerus Corporation's Intercept Blood System is approved in more than 25 countries and has helped save countless lives and prevent diseases for healthcare professionals and patients. The company has been recognized multiple times for its innovative products and services, including receiving the Gold Medal at the Edison Awards in 2017 and the Technology Pioneer Award from the World Economic Forum in 2016. In summary, Cerus Corporation is a successful biotechnology company that develops and distributes innovative technologies for the processing and transfusion of blood products. Through its technology and products, Cerus contributes to increasing the safety of blood transfusions by reducing the risk of infectious diseases and other potentially dangerous side effects. Cerus Corporation will continue to play an important role in the medical technology industry in the future. Cerus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Cerus's Employee Base
Cerus's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Cerus's operational capacity and future potential.
Year-to-Year Comparison
Assessing Cerus's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Cerus's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Cerus’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Cerus Stock
How many employees did Cerus have compared to the previous year?
Compared to the previous year, Cerus had 0% more employees.
What impact did the number of employees have on the company Cerus?
The number of employees has a direct impact on the efficiency and productivity of Cerus. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Cerus?
The number of employees can also have an impact on investors of Cerus, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Cerus affect the company?
An increase in equity of Cerus can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Cerus's equity affect the company?
A reduction in equity of Cerus can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Cerus?
Some factors that can influence the equity of Cerus include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Cerus so important for investors?
The equity of Cerus is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Cerus influence the company?
The number of employees at Cerus can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Cerus evolved in recent years?
In recent years, the number of employees at Cerus has changed by 0.
How many employees does Cerus currently have?
Cerus currently has 254 undefined employees.
Why is the number of employees important for investors of Cerus?
The number of employees is important for investors of Cerus as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Cerus take to change the number of employees?
To change the number of employees, Cerus can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Cerus pay?
Over the past 12 months, Cerus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerus is expected to pay a dividend of 0 USD.
What is the dividend yield of Cerus?
The current dividend yield of Cerus is .
When does Cerus pay dividends?
Cerus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cerus?
Cerus paid dividends every year for the past 0 years.
What is the dividend of Cerus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cerus located?
Cerus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cerus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cerus from 7/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.
When did Cerus pay the last dividend?
The last dividend was paid out on 7/3/2024.
What was the dividend of Cerus in the year 2023?
In the year 2023, Cerus distributed 0 USD as dividends.
In which currency does Cerus pay out the dividend?
The dividends of Cerus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cerus
Our stock analysis for Cerus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
